EDUARDO TANORI: Open Payments
NPI 1194502708 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,779 in 76 payments from 16 companies in 2025. Trend: 2023 $66 · 2024 $1,015 · 2025 $1,779
Food & beverage: $1,779
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 22 | $427 |
| Amgen Inc. | 8 | $256 |
| Novartis Pharmaceuticals Corporation | 13 | $224 |
| ABIOMED | 1 | $150 |
| Esperion Therapeutics, Inc. | 11 | $141 |
| PFIZER INC. | 4 | $110 |
| Inspire Medical Systems, Inc. | 1 | $102 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $92 |
| Alnylam Pharmaceuticals Inc. | 4 | $85 |
| Boston Scientific Corporation | 2 | $44 |
Products named: EVKEEZA, LEQVIO, NEXLETOL, ELIQUIS, KRYSTEXXA, INSPIRE, JARDIANCE, AMVUTTRA.
Industry payments across CA — which companies pay providers there.
